Mouse monoclonal antibodies to anthrax edema factor protect against infection

Infection and Immunity

Volumn 79, Issue 11, 2011, Pages 4609-4616

  Leysath, Clinton E ^a   Chen, Kuang Hua ^a   Moayeri, Mahtab ^a   Crown, Devorah ^a   Fattah, Rasem ^a   Chen, Zhaochun ^a   Das, Suman R ^a   Purcell, Robert H ^a   Leppla, Stephen H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; EDEMA FACTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; DISEASE COURSE; EPITOPE MAPPING; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; LETHAL GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; WESTERN BLOTTING;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HYBRIDOMAS; IMMUNIZATION; IMMUNOGLOBULIN G; MACROPHAGES; MICE; MICE, INBRED BALB C;

EID: 80855157115     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05314-11     Document Type: Article

References (35)

1. Abboud, N., et al. 2010. A requirement for Fc{gamma}R in antibody-mediated bacterial toxin neutralization. J. Exp. Med. 207:2395-2405.
2. Booth, M. G., J. Hood, T. J. Brooks, and A. Hart. 2010. Anthrax infection in drug users. Lancet 375:1345-1346.
3. Bouzianas, D. G. 2009. Medical countermeasures to protect humans from anthrax bioterrorism. Trends Microbiol. 17:522-528.
4. Chen, Z., et al. 2009. Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding. Proc. Natl. Acad. Sci. U. S. A. 106:13487-13492.
5. Drum, C. L., et al. 2002. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415:396-402.
6. Drum, C. L., et al. 2000. An extended conformation of calmodulin induces interactions between the structural domains of adenylyl cyclase from Bacillus anthracis to promote catalysis. J. Biol. Chem. 275:36334-36340.
7. Duesbery, N. S., et al. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734-737.
8. Dumetz, F., et al. 2011. Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am. J. Pathol. 178:2523-2535.
9. Duverger, A., et al. 2010. Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvant. J. Immunol. 185:5943-5952.
10. Firoved, A. M., et al. 2005. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167:1309-1320.
11. Fouet, A. 2009. The surface of Bacillus anthracis. Mol. Aspects Med. 30:374-385.
12. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. Hu, H., Q. Sa, T. M. Koehler, A. I. Aronson, and D. Zhou. 2006. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell. Microbiol. 8:1634-1642.
14. Kawasaki, H., Y. Kurosu, H. Kasai, T. Isobe, and T. Okuyama. 1986. Limited digestion of calmodulin with trypsin in the presence or absence of various metal ions. J. Biochem. 99:1409-1416.
15. Klimpel, K. R., N. Arora, and S. H. Leppla. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100.
16. Leppla, S. H. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. U. S. A. 79:3162-3166.
17. Leppla, S. H. 1984. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 17:189-198.
18. Little, S. F., S. H. Leppla, J. W. Burnett, and A. M. Friedlander. 1994. Structure-function analysis of Bacillus anthracis edema factor by using monoclonal antibodies. Biochem. Biophys. Res. Commun. 199:676-682.
19. Liu, S., et al. 2010. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe 8:455-462.
20. Maune, J. F., C. B. Klee, and K. Beckingham. 1992. Ca2+ binding and conformational change in two series of point mutations to the individual Ca(2+)-binding sites of calmodulin. J. Biol. Chem. 267:5286-5295.
21. Moayeri, M., and S. H. Leppla. 2009. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol. Aspects Med. 30:439-455.
22. Nguyen, M. L., S. Terzyan, J. D. Ballard, J. A. James, and A. D. Farris. 2009. The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes. Infect. Immun. 77:4714-4723.
23. Parcell, B. J., et al. 2011. Injection anthrax causing compartment syndrome and necrotising fasciitis. J. Clin. Pathol. 64:95-96. doi:10.1136/jcp. 2010.082586.
24. Pezard, C., P. Berche, and M. Mock. 1991. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59:3472-3477.
25. Pomerantsev, A. P., R. Sitaraman, C. R. Galloway, V. Kivovich, and S. H. Leppla. 2006. Genome engineering in Bacillus anthracis using Cre recombinase. Infect. Immun. 74:682-693.
26. Ramsay, C. N., et al. 2010. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveill. 15:pii:19465.
27. Shen, Y., et al. 2002. Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins. EMBO J. 21:6721-6732.
28. Shen, Y., N. L. Zhukovskaya, Q. Guo, J. Florian, and W. J. Tang. 2005. Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor. EMBO J. 24:929-941
29. Soelaiman, S., et al. 2003. Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough. J. Biol. Chem. 278:25990-25997.
30. Studier, F. W. 2005. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41:207-234.
31. Tang, W. J., and Q. Guo. 2009. The adenylyl cyclase activity of anthrax edema factor. Mol. Aspects Med. 30:423-430.
32. Ulmer, T. S., et al. 2003. Calcium dependence of the interaction between calmodulin and anthrax edema factor. J. Biol. Chem. 278:29261-29266.
33. Varughese, M., et al. 1998. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Mol. Med. 4:87-95.
34. Winterroth, L., J. Rivera, A. S. Nakouzi, E. Dadachova, and A. Casadevall. 2010. A neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax. Infect. Immun. 78:2890-2896.
35. Young, J. A., and R. J. Collier. 2007. Anthrax toxin: receptor-binding, internalization, pore formation, and translocation. Annu. Rev. Biochem. 76:243-265.